Back to today’s briefing

Story perspectives

U.S. Ends 22 mRNA Vaccines Amid Efficacy Concerns

8/6/2025

40 7

Summary

Story summary

The U.S. government has ended 22 mRNA vaccine programs due to poor efficacy against COVID and flu.
This decision was made without public acknowledgment of previous mandates or media narratives.
Funding will be redirected to broader vaccine platforms, though specifics remain unclear.
Numerous individuals continue to experience side effects, while dissenting opinions have faced censorship.

1 of 1

Story summary

The U.S. government has ended 22 mRNA vaccine programs due to poor efficacy against COVID and flu.
This decision was made without public acknowledgment of previous mandates or media narratives.
Funding will be redirected to broader vaccine platforms, though specifics remain unclear.
Numerous individuals continue to experience side effects, while dissenting opinions have faced censorship.